Chemohyperthermia with Mitomycin C and COMBAT system in High Risk Non-Muscle Invasive Bladder Cancer patients: Initial experience in a single center
Quality of life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Instillation matters.
The role of conductive hyperthermia with mitomycin in High Risk Non Muscle Invasive Bladder Cancer that has failed BCG therapy
Hyperthermic intravesical chemotherapy for BCG-unresponsive or BCG ineligible non-muscle invasive bladder cancer patients
Global Congress on Bladder Cancer 5-6th October 2017